Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 9Gynecologic 3Tumor-Agnostic 2Thoracic 2Head & Neck 2Genitourinary 2Gastrointestinal 2Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1CNS 1

Conditions

Neoplasms 2

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Population Groups × Tumor-Agnostic × Clear all
NCT06825429 2025-02-13

Group Exercise in Cancer Patients Under Active Treatment: Feasibility Pilot Study.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase NA Not yet recruiting
50 enrolled
Tumor-Agnostic

Neoplasms

NCT02550925 2020-03-26

Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors

University of Colorado, Boulder

Phase NA Completed
139 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡